Noven Financial Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$84K Buy
675
+264
+64% +$47.8K 0.07% 34
2019
Q4
$72K Sell
411
-2
-0.5% -$258 0.03% 31
2019
Q3
$62K Hold
413
0.03% 31
2019
Q2
$48K Hold
413
0.02% 33
2019
Q1
$70K Hold
413
0.04% 35
2018
Q4
$49K Buy
+413
New +$63.4K 0.05% 29
2018
Q3
Sell
-347
Closed -$229K 33
2018
Q2
$229K Hold
347
0.12% 30
2018
Q1
$353K Sell
347
-180
-34% -$151K 0.2% 27
2017
Q4
$643K Sell
527
-292
-36% -$137K 0.37% 21
2017
Q3
$150K Hold
819
0.09% 30
2017
Q2
$128K Hold
819
0.08% 34
2017
Q1
$197K Sell
819
-17
-2% -$4.57K 0.13% 31
2016
Q4
$226K Sell
836
-6
-0.7% -$1.43K 0.15% 29
2016
Q3
$187K Hold
842
0.13% 31
2016
Q2
$326K Hold
842
0.22% 26
2016
Q1
$569K Hold
842
0.4% 24
2015
Q4
$884K Hold
842
0.67% 20
2015
Q3
$730K Hold
842
0.59% 19
2015
Q2
$599K Buy
842
+302
+56% +$322K 0.44% 24
2015
Q1
$1.22M Sell
540
-255
-32% -$435K 0.88% 19
2014
Q4
$818K Hold
795
0.61% 20
2014
Q3
$842K Buy
795
+137
+21% +$231K 0.61% 22
2014
Q2
$1.65M Buy
658
+10
+2% +$20.4K 1.19% 17
2014
Q1
$1.23M Sell
648
-11,802
-95% -$27.9M 0.95% 20
2013
Q4
$26.6M Buy
+12,450
New +$29.4M 18.34% 1

Other funds holding AMPE

Noven Financial Group's AMPE Position: Q1 2020 in Review

Noven Financial Group increased its Ampio Pharmaceuticals Inc. (AMPE) stake by 64% in Q1 2020, buying an estimated $47.8K and bringing the position to 675 shares worth $84K. The position accounts for 0.07% of the portfolio, ranked #34.

Noven Financial Group first reported a position in AMPE in Q4 2013 and has held it in 25 quarters since. The position peaked at $26.6M in Q4 2013. 77 funds tracked by Wall St. Rank hold AMPE as of Q1 2020.

  • Noven Financial Group held 675 shares of Ampio Pharmaceuticals Inc. worth $84K as of Q1 2020.
  • Noven Financial Group bought 264 Ampio Pharmaceuticals Inc. shares in Q1 2020, an estimated $47.8K.
  • Ampio Pharmaceuticals Inc. made up 0.07% of Noven Financial Group's portfolio in Q1 2020, its #34 holding.
  • Noven Financial Group first reported a position in Ampio Pharmaceuticals Inc. in Q4 2013 and has held it in 25 quarters since.
  • Noven Financial Group's Ampio Pharmaceuticals Inc. position peaked at $26.6M in Q4 2013.
  • 77 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2020.

Based on Noven Financial Group's 13F filing for Q1 2020, filed 1 May 2020.